Community management: An effective model to reduce medication discontinuation rate in patients with schizophrenia
PLOS One · 2026
DOI: 10.1371/journal.pone.0324114 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Hua Ren und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, School of Life Science and Technology, University of Elec…. Hauptthemen laut MEDLINE: Schizophrenia, Antipsychotic Agents. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Medication discontinuation is highly prevalent among patients with schizophrenia and is associated with poor clinical outcomes. Although community-based management models have been implemented in China to support patients, recent evidence of their effectiveness in reducing medication discontinuation rates remains limited.
Methods
In this cross-sectional study, we surveyed 1,531 patients with schizophrenia under community management in Chengdu, China, using a multi-stage sampling approach. Data on treatment discontinuation (defined as cessation of all antipsychotics for >15 days without medical advice), socio-demographics, clinical characteristics, and service utilization were collected via face-to-face interviews. Univariate and multivariable logistic regression analyses were used to identify the factors associated with medication discontinuation.
Results
The overall rate of medication discontinuation was 4.1%. Multivariable analysis identified several independent risk factors for discontinuation: weak stable disease state (adjusted odds ratio [aOR] = 2.70, 95% confidence interval [CI]: 1.34–5.24), lack of insight (aOR for partial vs. no insight = 0.25, 95% CI: 0.08–0.80; aOR for full vs. no insight = 0.18, 95% CI: 0.05–0.65), presence of noticeable side effects (aOR = 1.98, 95% CI: 1.05–3.64), and absence of regular follow-up (aOR for intermittent vs. no follow-up = 0.38, 95% CI: 0.20–0.72; aOR for regular vs. no follow-up = 0.22, 95% CI: 0.10–0.44).
Conclusion
Community management was associated with a low rate of medication discontinuation in patients with schizophrenia. Key modifiable factors, including disease stability, insight, medication side effects, and follow-up adherence should be prioritized in community-based interventions to further improve treatment continuity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, P.R. China.
- Sleep Medicine Center, Mental Health Center, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, P.R. China.
- Mental Health Center, National Center for Mental Disorders, West China Hospital, Sichuan University, Chengdu, P.R. China.
ORCID-Profile: Hua Ren, Zaiquan Dong
Zitieren
APA
Ren, H., Yang, Q., He, C., Jiao, J., & Dong, Z. (2026). Community management: An effective model to reduce medication discontinuation rate in patients with schizophrenia. PLOS One. https://doi.org/10.1371/journal.pone.0324114
Vancouver
Ren H, Yang Q, He C, Jiao J, Dong Z. Community management: An effective model to reduce medication discontinuation rate in patients with schizophrenia. PLOS One. 2026. doi:10.1371/journal.pone.0324114
BibTeX
@article{Ren2026,
author = {Ren, Hua and Yang, Qin and He, Changjiu and Jiao, Jian and Dong, Zaiquan},
title = {Community management: An effective model to reduce medication discontinuation rate in patients with schizophrenia},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0324114}
}
EUVIMED